TTD | Drug: D05STL

Drug General Information
Drug ID	D05STL
Former ID	DNCL002012
Drug Name	ARRY-502
Indication	Allergic asthma [ICD9: 493, 995.3; ICD10:J45, T78.4]		Phase 2	[523846]
Company	Array BioPharma
Target and Pathway
Target(s)	Putative G-protein coupled receptor 44	Target Info	Modulator	[550275]
Reactome	Prostanoid ligand receptors
Reactome	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 523846	ClinicalTrials.gov (NCT01561690) A Study of ARRY-502 in Patients With Persistent Asthma. U.S. National Institutes of Health.
Ref 550275	Clinical pipeline report, company report or official report of Array BioPharma (Drug: ARRY-502).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information